第一作者单位：[1]Huazhong Univ Sci & Technol, Hepat Surg Ctr, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China[2]Hubei Prov Clin Med, Res Ctr Hepat Surg, Wuhan 430030, Hubei, Peoples R China
通讯作者：
通讯机构：[1]Huazhong Univ Sci & Technol, Hepat Surg Ctr, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China[2]Hubei Prov Clin Med, Res Ctr Hepat Surg, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714)：
Liu Furong,Long Xin,Ji Guibao,et al.Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes[J].JOURNAL OF INFECTION.2020,81(2):E178-E180.doi:10.1016/j.jinf.2020.06.029.
APA：
Liu, Furong,Long, Xin,Ji, Guibao,Zhang, Bixiang,Zhang, Wanguang...&Chen, Xiaoping.(2020).Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes.JOURNAL OF INFECTION,81,(2)
MLA：
Liu, Furong,et al."Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes".JOURNAL OF INFECTION 81..2(2020):E178-E180
